Clinical Trial Update: Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating autologous bone mesenchymal stem cells (MSV-H) for treating maxillary cysts with associated bone loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss
• Maxillary Cyst

Drugs mentioned

• MSV-H Autologous Bone Mesenchymal Stem Cells (autologous bone mesenchymal stem cells)

Snippet

Sponsor: Red de Terapia Celular | Conditions: Maxillary Cyst, Bone Loss of Substance | Phase 1, Phase 2 | Status: COMPLETED